Odds of IBS, Functional Dyspepsia Increased After Acute Gastroenteritis Episode
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 17, 2024 -- A considerable proportion of individuals experiencing acute gastroenteritis develop postinfection irritable bowel syndrome (PI-IBS) and postinfection functional dyspepsia (PI-FD), according to a review published online July 16 in Gut.
Serena Porcari, M.D., from Università Cattolica del Sacro Cuore in Rome, and colleagues conducted a systematic review and meta-analysis to examine the prevalence of PI-IBS or PI-FD after acute gastroenteritis using data from observational studies recruiting 50 or more adults. Forty-seven studies were eligible, with 28,170 individuals.
The researchers found that the overall prevalence of PI-IBS was 14.5 percent and the prevalence of PI-FD was 12.7 percent. In 39.8 percent of individuals, IBS persisted in the long term (greater than five years of follow-up) after diagnosis. Compared with nonexposed controls, individuals experiencing acute gastroenteritis had significantly higher odds of IBS and FD (odds ratios, 4.3 and 3.0, respectively). The strongest association was seen for PI-IBS with parasites (prevalence, 30.1 percent), but only in two studies, followed by bacteria and viruses (18.3 and 10.7 percent). The highest PI-IBS prevalence was seen in association with Campylobacter in available studies (20.7 percent), while the highest odds for PI-IBS were yielded by Proteobacteria and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; odds ratio, 5.4 for each). The prevalence of PI-FD was 10.0 and 13.6 percent for SARS-CoV-2 and bacteria (Enterobacteriaceae, 19.4 percent), respectively.
"Our findings provide an update to the epidemiology of PI-IBS and PI-FD and of the likelihood of developing them after acute gastroenteritis," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Increase in Chronic Digestive Disorders Seen During Pandemic
WEDNESDAY, July 9, 2025 -- There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a...
Bariatric Surgery Complications Increase With Initial Body Mass Index
TUESDAY, July 1, 2025 -- The higher a person’s body mass index (BMI), the higher their risk for complications after bariatric surgery, such as higher rates of emergency...
Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile
WEDNESDAY, June 25, 2025 -- Fecal microbiota transplantation (FMT) could be considered as first-line therapy for primary Clostridioides difficile infection (CDI), according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.